MyCardium AI Tech Stack

AI-powered cardiac imaging analysis for clinical diagnosis and trials

Software Development Liverpool, Merseyside 11–50 employees Founded 2022 Public Company

MyCardium AI builds human-in-the-loop AI for cardiac imaging interpretation, deployed across hospitals and clinical trial networks. The tech stack reveals a healthcare-grade cloud operation: AWS, GCP, Azure, DICOM/HL7/FHIR standards, plus security layers (Tailscale, Azure AD, Terraform). Pain points cluster heavily around compliance (GDPR, HIPAA, ISO 27001) and operational reliability—login failures delaying diagnoses and imaging downtime surface repeatedly—indicating the company is solving for clinical-grade uptime and regulatory rigor as much as AI accuracy. Recent hiring velocity leans support and engineering, aligned with their active push to harden cloud infrastructure and automate access management.

Tech Stack 19 technologies

Core StackCloudflare AWS Docker Python GitHub Actions Azure AD Terraform Linux GCP Tailscale Azure PowerShell PACS Hetzner Microsoft 365 Windows DICOM HL7 FHIR

What MyCardium AI Is Building

◆Challenges

Routine cloud support work
Compliance with gdpr, hipaa, iso 27001
Migrating legacy systems to cloud
Fast, secure and scalable ai tools
Login issues delaying diagnoses
Imaging system downtime
Maintaining security compliance
Ensuring healthcare it compliance
Implementing ai solutions in clinical workflow
Delayed diagnoses due to login issues

▲Active Projects

Secure cloud systems for ai imaging products
Cloud integration project
Linking cloud to ci/cd tools
Automate key processes
Implementation of echoconfidence
Optimisation of echoconfidence
Cloud services configuration
Access management automation
Saas tool rollout

Hiring Activity

Accelerating7 roles · 4 in 30d

Department

Support

Engineering

Healthcare

Ops

Seniority

Mid

Junior

Company intelligence

Find more companies like MyCardium AI by tech stack, pain points and active projects

Get started free

About MyCardium AI

MyCardium AI develops AI diagnostic tools for cardiac imaging, founded in 2022 as a University College London spin-out by leading cardiologists and imaging researchers. The product line includes 1CMR Pro (FDA 510(k) cleared, CE Class IIb certified) for cardiac magnetic resonance analysis and EchoConfidence for echocardiogram interpretation, both designed so clinicians validate AI suggestions rather than trust them blindly. The company also operates a Core Lab service for multi-center clinical trials, standardizing imaging endpoints for drug development. Based in Liverpool with ISO 13485 certification, MyCardium serves hospitals, research programs, and trial networks internationally. Their roadmap centers on secure cloud deployment, CI/CD automation, and healthcare IT compliance—the operational backbone needed to scale AI tools into high-stakes clinical workflows.

HeadquartersLiverpool, Merseyside

Company Size11–50 employees

Founded2022

Hiring MarketsUnited Kingdom

Frequently Asked Questions

What tech stack does MyCardium AI use?

Cloud infrastructure on AWS, GCP, and Azure; Python for AI/ML; Docker containerization; healthcare standards (DICOM, HL7, FHIR); identity via Azure AD; security tools Cloudflare, Tailscale; CI/CD via GitHub Actions and Terraform.

Is MyCardium AI hiring engineers?

Yes. Engineering roles are active with mid-level seniority focus. Support, healthcare, and ops roles are also open. Hiring is concentrated in the United Kingdom with accelerating velocity.

What regulatory certifications does MyCardium AI have?

FDA 510(k) clearance and CE Class IIb certification for 1CMR Pro; ISO 13485 certification for medical device quality; compliance frameworks include GDPR, HIPAA, and ISO 27001.